Pang X, Zhang B, Mu G, Xia J, Xiang Q, Zhao X
RSC Adv. 2022; 8(61):34783-34792.
PMID: 35547066
PMC: 9086869.
DOI: 10.1039/c8ra06311g.
Wang Z, Paragas E, Nagar S, Korzekwa K
Drug Metab Dispos. 2021; 49(12):1090-1099.
PMID: 34503952
PMC: 11022900.
DOI: 10.1124/dmd.121.000553.
Zhang R, Dong K, Wang Z, Miao R, Lu W, Wu X
Pharmaceutics. 2021; 13(8).
PMID: 34452222
PMC: 8399842.
DOI: 10.3390/pharmaceutics13081261.
Wright W, Chenge J, Chen T
Liver Res. 2020; 3(3-4):132-142.
PMID: 32789028
PMC: 7418881.
DOI: 10.1016/j.livres.2019.08.001.
Kiani Y, Ranaghan K, Jabeen I, Mulholland A
Int J Mol Sci. 2019; 20(18).
PMID: 31510073
PMC: 6769491.
DOI: 10.3390/ijms20184468.
Neonatal cytochrome P450 CYP3A7: A comprehensive review of its role in development, disease, and xenobiotic metabolism.
Li H, Lampe J
Arch Biochem Biophys. 2019; 673:108078.
PMID: 31445893
PMC: 6739124.
DOI: 10.1016/j.abb.2019.108078.
Characterization of kinetics of human cytochrome P450s involved in bioactivation of flucloxacillin: inhibition of CYP3A-catalysed hydroxylation by sulfaphenazole.
Dekker S, Dohmen F, Vermeulen N, Commandeur J
Br J Pharmacol. 2018; 176(3):466-477.
PMID: 30447161
PMC: 6329626.
DOI: 10.1111/bph.14548.
Identification and quantification of domestic feline cytochrome P450 transcriptome across multiple tissues.
Visser M, Weber K, Lyons L, Rincon G, Boothe D, Merritt D
J Vet Pharmacol Ther. 2018; 42(1):7-15.
PMID: 30171610
PMC: 6322962.
DOI: 10.1111/jvp.12708.
The prognostic value of differentially expressed CYP3A subfamily members for hepatocellular carcinoma.
Yu T, Wang X, Zhu G, Han C, Su H, Liao X
Cancer Manag Res. 2018; 10:1713-1726.
PMID: 29983591
PMC: 6025769.
DOI: 10.2147/CMAR.S159425.
Use of In Vitro and Predictive In Silico Models to Study the Inhibition of Cytochrome P4503A by Stilbenes.
Basheer L, Schultz K, Fichman M, Kerem Z
PLoS One. 2015; 10(10):e0141061.
PMID: 26485399
PMC: 4618141.
DOI: 10.1371/journal.pone.0141061.
Structure-Based Inhibitor Design for Evaluation of a CYP3A4 Pharmacophore Model.
Kaur P, Chamberlin A, Poulos T, Sevrioukova I
J Med Chem. 2015; 59(9):4210-20.
PMID: 26371436
PMC: 4998966.
DOI: 10.1021/acs.jmedchem.5b01146.
Measuring specificity in multi-substrate/product systems as a tool to investigate selectivity in vivo.
Kuo Y, Henry R, Andrews A
Biochim Biophys Acta. 2015; 1864(1):70-6.
PMID: 26321598
PMC: 4924809.
DOI: 10.1016/j.bbapap.2015.08.011.
Interactions between CYP3A4 and Dietary Polyphenols.
Basheer L, Kerem Z
Oxid Med Cell Longev. 2015; 2015:854015.
PMID: 26180597
PMC: 4477257.
DOI: 10.1155/2015/854015.
Current Approaches for Investigating and Predicting Cytochrome P450 3A4-Ligand Interactions.
Sevrioukova I, Poulos T
Adv Exp Med Biol. 2015; 851:83-105.
PMID: 26002732
PMC: 4532289.
DOI: 10.1007/978-3-319-16009-2_3.
Characterization of T-5 N-oxide formation as the first highly selective measure of CYP3A5 activity.
Li X, Jeso V, Heyward S, Walker G, Sharma R, Micalizio G
Drug Metab Dispos. 2013; 42(3):334-42.
PMID: 24335391
PMC: 3935135.
DOI: 10.1124/dmd.113.054726.
Imidazopyridines as selective CYP3A4 inhibitors.
Song X, Li X, Ruiz C, Yin Y, Feng Y, Kamenecka T
Bioorg Med Chem Lett. 2012; 22(4):1611-4.
PMID: 22264486
PMC: 4481867.
DOI: 10.1016/j.bmcl.2011.12.125.
Experimental approaches to evaluate activities of cytochromes P450 3A.
Borek-Dohalska L, Hodek P, Hudecek J, Stiborova M
Interdiscip Toxicol. 2011; 1(2):155-9.
PMID: 21218106
PMC: 2993482.
DOI: 10.2478/v10102-010-0032-0.
Automated selection of compounds with physicochemical properties to maximize bioavailability and druglikeness.
Oashi T, Ringer A, Raman E, MacKerell A
J Chem Inf Model. 2010; 51(1):148-58.
PMID: 21142079
PMC: 3160130.
DOI: 10.1021/ci100359a.
Development of a fluorescence-based, ultra high-throughput screening platform for nanoliter-scale cytochrome p450 microarrays.
Sukumaran S, Potsaid B, Lee M, Clark D, Dordick J
J Biomol Screen. 2009; 14(6):668-78.
PMID: 19525490
PMC: 5333991.
DOI: 10.1177/1087057109336592.
Modeling kinetics of subcellular disposition of chemicals.
Balaz S
Chem Rev. 2009; 109(5):1793-899.
PMID: 19265398
PMC: 2682929.
DOI: 10.1021/cr030440j.